Get the Stockscreener App
0.0499
19.65%
-0.0122
Pre-market:
.05
0.0001
+0.20%
Aditxt Inc stock is traded at $0.0499, with a volume of 34.19M.
It is down -19.65% in the last 24 hours and down -98.44% over the past month.
Aditxt Inc is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system. It develops products designed to induce tolerance to transplanted organs. Its portfolio consists of two programs Adimune and AditxtScore. It firm's immunosuppressive (anti-rejection) drugs have made possible life-saving organ transplantation procedures and blocking of unwanted immune responses in autoimmune diseases. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) ADI-100, which utilizes a novel approach that mimics, the way bodies naturally induce tolerance to tissues. The company operates in one segment, which is focused on the discovery and development of biopharmaceutical products.
See More
Previous Close:
$0.0621
Open:
$0.05
24h Volume:
34.19M
Relative Volume:
7.92
Market Cap:
$40,714
Revenue:
$3,200
Net Income/Loss:
$-42.79M
P/E Ratio:
-0.000007
EPS:
-7534.7458
Net Cash Flow:
$-25.70M
1W Performance:
-55.84%
1M Performance:
-98.44%
6M Performance:
-99.99%
1Y Performance:
-100.00%
1-Day Range:
$0.0463
$0.054
1-Week Range:
$0.0463
$0.1289
52-Week Range:
$0.0463
$53,451.08
Aditxt Inc Stock (ADTX) Company Profile
Name
Aditxt Inc
Sector
Industry
Phone
909-488-0844
Address
737 N. FIFTH STREET, SUITE 200, RICHMOND
Compare ADTX vs VRTX, REGN, ARGX, ALNY, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ADTX
Aditxt Inc
|
0.0499 | 50,669 | 3,200 | -42.79M | -25.70M | -7,534.75 |
VRTX
Vertex Pharmaceuticals Inc
|
442.96 | 113.41B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
611.34 | 66.62B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
882.41 | 55.43B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
292.16 | 40.46B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
148.49 | 31.73B | 742.00K | -1.37B | -1.07B | -7.0731 |
Aditxt Inc Stock (ADTX) Latest News
HRT Financial sells $45,598 of Aditxt shares By Investing.com - Investing.com India
HRT Financial sells $45,598 of Aditxt shares - Investing.com
HRT Financial exits Aditxt, Inc. (ADTX) position after open-market buy and sell - Stock Titan
HRT Financial (ADTX) discloses 505,302 Aditxt common shares in Form 3 filing - Stock Titan
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Aditxt Announces Immediate Resignations of Key Leadership Roles - The Globe and Mail
Aditxt, Inc. Files Form 8-K Current Report with NASDAQ Trading Symbol ADTX on June 2, 2026 - Minichart
Top 10 Weekly Stock Market Losers: Massive Declines Hit Speculative Stocks - stl.news
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
ADTX News | ADITXT INC (NASDAQ:ADTX) - ChartMill
Aditxt Company Profile & Introduction - Moomoo
ADTX Stock Price, Quote & Chart | ADITXT INC (NASDAQ:ADTX) - ChartMill
Aditxt Appoints Interim CEO Amid Broad Leadership Transition - The Globe and Mail
Aditxt, Inc. Appoints Jeffrey M. Busch as Interim Chief Executive Officer, Founder and Former CEO of $1B NYSE Enterprise Which Delivered 8.5% Dividends to Shareholders - marketscreener.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Why Hewlett Packard Enterprise Shares Are Trading Higher By Over 26%; Here Are 20 Stocks Moving Premarket - Sahm
Aditxt Appoints Jeffrey M. Busch as Interim CEO - Intellectia AI
12 Health Care Stocks Moving In Monday's After-Market SessionAbivax (NASDAQ:ABVX), Aditxt (NASDAQ:ADTX - Benzinga
Aditxt Appoints Jeffrey M. Busch as Interim CEO to Lead Accelerated Growth in Precision Oncology Diagnostics - Minichart
Aditxt Names Jeffrey Busch as Interim CEO - marketscreener.com
Aditxt, Inc. has appointed Jeffrey M. Busch as interim CEO - Bitget
Aditxt names Jeffrey Busch as interim CEO By Investing.com - Investing.com India
Aditxt, Inc. Announces CEO Changes - marketscreener.com
Aditxt appoints Jeffrey M. Busch as interim CEO; founder and former CEO of $1B NYSE enterprise which delivered ~8.5% dividends to Shareholders - marketscreener.com
Aditxt, Inc. Appoints Jeffrey M. Busch as Interim Chief Executive Officer; Founder and Former CEO of $1B NYSE Enterprise Which Delivered ~8.5% Dividends to Shareholders - marketscreener.com
Ex-$1B NYSE healthcare real estate CEO with ~8.5% dividends now leads Aditxt - Stock Titan
Why Taylor Morrison Home Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket - Sahm
Aditxt, Inc. Receives Nasdaq Delisting Notice Due to Stockholders’ Equity Deficiency (May 2026) - Minichart
Aditxt appoints Jeffrey M Busch as interim CEO - MSN
Aditxt Faces Nasdaq Delisting Risk After Equity Shortfall - TipRanks
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Deeply negative equity puts Aditxt (NASDAQ: ADTX) at heightened Nasdaq delisting risk - Stock Titan
ADTX - Finviz
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Aditxt, Inc.(NasdaqCM: ADTX) added to NASDAQ Composite Index - marketscreener.com
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Aditxt, Inc.(NasdaqCM: ADTX) dropped from NASDAQ Composite Index - marketscreener.com
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Nasdaq Surges Over 1%; Chicago Fed National Activity Index Rises In April - Benzinga
Why JOYY Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket - Benzinga
ADTX Q3 2025 Earnings: Significant Loss per Share Amidst No Revenue Reported; Stock PlungesMid-Term Outlook - The Legal Advocate
Aditxt (NASDAQ: ADTX) asks shareholders to approve reverse stock split through 2027 - Stock Titan
$ADTX Stock Is Down 47% Today. Here's What We See in Our Data. - Moomoo
Dow Jumps 250 Points; BJ's Wholesale Shares Fall After Q1 ResultsAditxt (NASDAQ:ADTX), Akari Therapeut - Benzinga
Why Estee Lauder Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket - Benzinga
Evofem Biosciences Announces Financial Results for the First Quarter of 2024 - Quantisnow
ADTX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Aditxt (NASDAQ: ADTX) Q1 loss deepens as equity turns negative and going concern raised - Stock Titan
Aditxt Inc Stock (ADTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.05%
0.26%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):